Influenza A H1N1 2009 vaccine in juvenile dermatomyositis reduced immunogenicity in patients under immunosuppressive therapy
Table III.ositis (JDM) patients and controls.
Adverse events of in uenza A/H1N1/2009 vaccination in juvenile dermatomy-Variables Controls p-value
(n=30) JDM (n=81)Local reactions Pain Redness 9 (30) 0.472 Swelling 0 19 1.0 Itching
0 1.0Systemic reactions
0 2 (23)
2 (2) 1 (2) (1) 1.0 Arthralgia Fever 1 2 1.0 Headache 1 (3) 1.0 Myalgia 5 (3) 18 3 (2) (4) (22) 0.606 Sore throat 1 (17) 0 (3) 6 0.671 Cough 5 (7) 0.321 Diarrhea 0 5 (6) 0.321 Rhinorrhea
0 2 (6) 1.0 Nasal congestion 4 0 (13)
3 (2) 3 (4) (4)
0.0830.561
Values expressed in n (%).
thermore, therapy was stable through-out the study in all patients.
largest in uenza vaccine (11-13).
JDM population that received Adverse events
After Local H1N1/2009 immunisation with in uenza A events were mild and had similar fre-and systemic vaccine adverse sponse was impaired in JDM patients, vaccine, the immunore-quencies in JDM and controls (as (Table for the same vaccine in adult DM (26). also observed in our recent report adverse events.
III). None of them had p>0.05) severe Similarly, conversion we Discussion
in rates evidenced for the reduced same sero-This lupus erythematosus (JSLE) and 93 ju-a cohort of 99 of juvenile systemic vaccine vanted study revealed that the non-adju-venile idiopathic arthritis (JIA) patients immunisation in uenza (13). Further studies will be performed tients is effective A H1N1/2009 in JDM virus pa-to course and immunosuppressive therapy and identi ed that JDM chronic H1N1/2009 assess the may eters and the potential deleterious effect vaccine in uence in disease of in uenza param-A body production.
hamper the vaccine induced anti-of The advantage of the present study was ments in each of these diseases.
therapy in immunoresponse treat-the In contrast, previous studies in juvenile of patients that ful lled the criteria for inclusion of a homogenous group rheumatic JDM (19) and the comparison with an very age-matched control group, tions limited diseases number (27), of JDM including popula-a cine ef cacy has a distinct since pattern vac-in tory (11, 12), demonstrated satisfac-pediatric and cluded independent of glucocorticoid and im-pandemic immunogenicity in uenza with vaccination, seasonal age, only population patients (15). over We also in-munosuppressive therapies. In addition, and children who had reduced humoral excluding the group 9 of years infants of the lower seroconversion rates in JDM response patients cannot be explained by previ-vaccine and required two doses of this to in uenza A H1N1/2009 ous vaccine (15, 16). Additionally, the use enza vaccine.
immunisation with seasonal in u-of non-adjuvant vaccine was chosen to The avoid sion four (25). an autoimmune-related disease therefore, had patients chronic course without seroconver-rare disease resulted, however, in a lim-The prospective design of this nosuppressants combination in spite of they were still under of JDM immu-and ited number of participants, and to our mild knowledge our study encompasses the cocorticoid was the major factor for the disease activity parameters. Glu-reduced overall immune response of
587
pandemic with diseases, juvenile vaccine autoimmune in our recent rheumatic study JIA present evaluation (13).
and 18 mainly JDM comprised also included by JSLE, in the We pressive have antibody response in JDM patients. In therapy identi ed may that hamper immunosup-vaccine our pediatric previous phopenia and immunosuppressants did autoimmune study including diseases, several lym-not the vious studies reported no effect of im-same in uence vaccine seroconversion (13). Likewise, against pre-munosuppressants with in uenza vaccine (11) in patients with seasonal (12, in 27) immunogenicity and pandemic rheumatic diseases. In contrast, gluco-corticoid use was associated with lower humoral and/or immunosuppressant and cell-mediated responses against the H1N1 strain of seasonal in uenza vac-cine in adult systemic lupus erythema-tosus (28, 29) and rheumatoid arthritis patients (30). In a recent study on pan-demic in uenza A H1N1/2009 vaccine in improved adult lupus, therapy (17).
in those immunogenicity under antimalarials was As other regards eters, clinical the and possible laboratorial in uence of nding lymphopenia seem to interfere with immunoresponse in these patients was not and a does relevant param-not to pandemic vaccine in JDM. Of note, in ni cantly associated with reduced lym-vaccination failure was lupus, sig-phocyte count (31).
The vance of disease activity, as determined evaluation of the potential rele-by antibody response was impaired by the JDM score, in pandemic vaccine small moderate or severe ares in our cohort representation of patients with that excluded hospitalised patients. Dis-ease safety is reinforced by our ndings of muscle evaluation parameters through-stable JDM scores and laboratorial out the study, including the borderline higher levels of aldolase in the non-se-roconverted group. In this regard, stud-ies with adult SLE have demonstrated no effect of seasonal in uenza immuni-sation on disease ares (18).
Of cine note, JDM patients, as no serious short-term
was in uenza A well tolerated H1N1/2009 and safe vac-in
Influenza (the flu)_英语学习_外语学习_教育专区。流感预防Influenza (the flu) By Salwa Hassan Teama Ain Shams University Difference Between Cold or FLU ...
流感病毒与流感疫苗 - Influenza and Influenza Vaccines_生物学_自然科学_专业资料。流感病毒与流感疫苗 - Influenza and Influenza Vaccines...
Influenza (Flu) What Everyone Should Know About Flu and the Flu Vaccine What is the flu? The flu is a contagious respiratory illness caused by ...
Influenza Miley ClassB Influenza, commonly referred to as the flu, is an infectious disease caused by RNA viruses of the family Orthomyxoviridae (the ...
Influenza (flu): ? is a highly infectious viral disease caused by various types of influenza viral strains ? Seasonal Influenza In Hong Kong, the ...
42页 免费 Influenza 32页 10财富值搜你所想,读你所爱 拒绝盗版,营造绿色文库 如要投诉违规内容,请到百度文库投诉中心;如要提出功能问题或意见建议,请点击...
www.themegallery.com Spring - prone diseases Epidemic cerebrospinal meningitis、 、 influenza , mumps and other respiratory diseases流脑、流感、流腮等呼吸道...
Summer 2008 Workshop in Biology and Multimedia for High School Teachers INFLUENZA VIRUS: A Model for Learning About Disease Laurie St.Pierre Sandwich High...
流行性感冒病毒 influenza virus 流行性感冒病毒(influenza virus)简称流感 病毒。按病毒核蛋白(nucleocapside protein,NP) 和基质蛋白(matrix protein, M)分成甲(A)...
流行性感冒 influenza 定义:流行性感冒简称流感,是 由流行性感冒病毒引起的急性呼 吸道传染病。 特征:病毒极易变异; 传染性强; 全身症状重; 呼吸道症状轻。 ...
热门文档